Diagnosis of primary hyperfibrinolysis and in vitro investigation of the inhibitory effects of tranexamic acid in a group of dogs with sarcomas – A pilot study
- 1 May 2021
- journal article
- research article
- Published by Elsevier in Research in Veterinary Science
- Vol. 136, 472-477
Abstract
No abstract availableKeywords
Funding Information
- University of Copenhagen Faculty of Health and Medical Sciences
This publication has 37 references indexed in Scilit:
- Endogenous fibrinolytic potential in tissue‐plasminogen activator‐modified thromboelastography analysis is significantly decreased in dogs suffering from diseases predisposing to thrombosisVeterinary Clinical Pathology, 2013
- Vascular endothelial-cadherin and vascular stabilityCurrent Opinion in Hematology, 2012
- Haemostatic alterations in a group of canine cancer patients are associated with cancer type and disease progressionActa Veterinaria Scandinavica, 2012
- Concurrent Diseases and Conditions in Dogs with Splenic Vein ThrombosisJournal of Veterinary Internal Medicine, 2010
- Tissue plasminogen activator induced fibrinolysis: standardization of method using thromboelastographyBlood Coagulation & Fibrinolysis, 2010
- Thromboelastographic Evaluation of Hemostatic Function in Dogs with Disseminated Intravascular CoagulationJournal of Veterinary Internal Medicine, 2008
- Regulation of local availability of active tissue‐type plasminogen activator in vivo in manJournal of Thrombosis and Haemostasis, 2004
- Hyperfibrinolysis.Journal of Clinical Pathology, 1996
- Hemostatic Abnormalities in Dogs With HemangiosarcomaJournal of Veterinary Internal Medicine, 1991
- In Vivo and Post Mortem Dissolution Rates of Pulmonary Emboli and Venous Thrombi in the DogCirculation, 1973